A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell- mediated immunity in protection against Bordetella pertussis

Infection and Immunity

Volumn 66, Issue 2, 1998, Pages 594-602

  Mills, Kingston H G ^a   Ryan, Mark ^a   Ryan, Elizabeth ^a   Mahon, Bernard P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; BORDETELLA PERTUSSIS; CELL PROTECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; GENE DISRUPTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; VACCINATION;

EID: 0031882161     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.2.594-602.1998     Document Type: Article

References (40)

1. Ad Hoc Group for the Study of Pertussis Vaccines, 1997. A randomized controlled trial of a two-component, a three component and a five-component acellular pertussis vaccine and a British whole-cell pertussis vaccine. Lancet 350:1569-1577.
2. Ausiello, C. M., F. Urbani, A. La Sala, R. Lande, and A. Cassone. 1997, Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect. Immun. 65:2168-2174.
3. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. G. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
4. Bromberg, K., G. Tannis, and P. Steiner. 1991. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect. Immun. 59:4715-4719.
5. Cassone, A., C. M. Ausiello, F. Urbani, R. Lande, S. Giuliano, for the Progetto Pertosse-CMI Working Group. 1997. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch. Pediatr. Adolesc. Med. 151:283-289.
6. Centers for Disease Control and Prevention- 1997. Pertussis vaccination: use of acellular pertussis vaccines among infants and young children-recommendations of the advisory committee on immunization practices (ACIP). Morbid. Mortal. Weekly Rep. 46:(RR)1-(RR)25.
7. Cherry, J. D., P. A. Brunnell, G. S. Golden, and D. T. Karzon. 1988. Report of the task force on pertussis and pertussis immunization-1988. Pediatrics 81(Suppl.):939-984.
8. Church, M. A. 1978. Evidence of whooping-cough-vaccine efficacy from 1978 whooping-cough epidemic in Hertfordshire. Lancet ii: 188-190.
9. + T cells in vivo. J. Immunol. 155:3734-3741.
10. Edwards, K. M., B. D. Meade, M. D. Decker, G. F. Reed, M. B. Rennels, M. C. Steinhoff, E. L. Anderson, J. A. Enguland, M. E. Pichichero, and M. A. Deioria. 1995. Comparison of thirteen acellular pertussis vaccines: overview and serological response. Pediatrics 96:548-557.
11. Greco, D., S. Salmaso, P. Mastrantonio, M. Guiliano, A. G. Tozzi, A. Anemona, M. L. Giori Delgi Atti, A. Giammanco, P. Panel, W. C. Black-welder, D. L. Klein, S. G. F. Wassilak, and the Progetto Pertosase Working Group. 1996. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N. Engl. J. Med. 334:341-348.
12. Gustafsson, L., H. O. Hallander, P. Olin, E. Reizenstein, and J. Storsaeter. 1996. A controlled trial of a two-component acellular, a five component acelluiar, and a whole cell pertussis vaccine. N. Engl. J. Med. 334:349-355.
13. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bleuthmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the IFN-γ receptor. Science 259:1742-1745.
14. Kendrick, P. L. 1947. Mouse protection tests in the study of pertussis vaccine. Am. J. Public Health 37:803-810.
15. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423-426.
16. Kuhn, R., K. Rajewsky, and W. Muller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
17. Loscher, C. E., S. Donnelly, M. A. Lynch, and K. H. G. Mills. 1997. Proinflammatory cytokines and fever: involvement in the neurological sequelae of Bordetella pertussis infection and immunization. Immunology 92(Suppl. 1):66.
18. Mahon, B. P., M. Ryan, F. Griffin, and K. H. G. Mills. 1996. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect. Immun. 64:5295-5301.
19. Mahon, B. P., F. Griffin, B. Sheahan, and K. H. G. Mills, 1997. Atypical disease following Bordetella pertussis respiratory infection of mice with targeted disruptions in IFN-γ receptor or immunoglobulin μ chain genes, J. Exp. Med, 186:1843-1851.
20. Medical Research Council, Whooping Cough Immunisation Committee. 1956. Vaccination against whooping-cough: relation between protection in children and results of laboratory tests. Br. Med. J. 2:454-454.
21. Miller, E., L. A. E. Ashworth, K. Redhead, C. Thornton, P. A. Waight. and T. Coleman. 1997. Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. Vaccine 15:51-60.
22. Mills, K. H. G., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
23. Oda, M., J. L. Cowell, D. G. Burstyn, S. Thaib, and C. R. Manclark. 1985. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice. Infect. Immun. 47:441-445.
24. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339-1344.
25. PHLS Epidemiological Research Laboratory and 21 area health authorities. 1982. Efficacy of pertussis vaccination in England. Br. Med. J. 285:357-359.
26. Pittman, M., B. L. Furman and A. C. Wardlaw. 1980. Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses. J. Infect. Dis. 142:56-66.
27. Pizza, M. G., A. Covacci, A. Bartoloni, M. Pergini, L. Nencioni, M. T. De Magistris, L. Villa, D. Nucci, R. Manetti, M. Bugnoli, F. Giovannoni, R. Oliveri, J. Barbieri, H. Sato, and R. Rappuoli. 1989. Mutants of pertussis toxin suitable for vaccine development. Science 246:497-500.
28. Redhead, K., A. Barnard, J. Watkins, and K. H. G. Mills. 1993. Effective immunisation against Bordetella pertussis respiratory infection in mice is dependent on the induction of cell mediated immunity. Infect. Immun. 61:3190-3198.
29. Robinson, A., L. I. Irons, and L. A. E. Ashworth. 1985. Pertussis vaccine: present status and future prospects. Vaccine 3:11-22.
30. Ryan, M., G. Murphy, L. Gothefors, L. Nilsson, J. Storsaeter, K. H. G. Mills. 1997. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 Th cells. J. Infect. Dis. 175:1246-1250.
31. Ryan, M., L. Gothefors, J. Storsaeter, and K. H. G. Mills, 1997. B. pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokinc profiles in infants and mice. Dev, Biol. Stand. 89:251-259.
32. Ryan, M., G. Murphy, L. Nilsson, F. Shackley, L. Gothrfors, K. Ømar, E. Miller, J. Storsaeter, and K. H. G. Mills. 1998. Distinct Th cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93:1-10.
33. Sato, Y., K. Izumiya, H. Sato, J. L. Cowell, and C. R. Manclark. 1980. Aerosol infection of mice with Bordetella pertussis. Infect. Immun. 29:261-266.
34. Sato, H., and Y. Sato. 1984, Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect. Immun. 46:415-421.
35. Saukkonen, K., C. Cabellos, M. Burroughs, S. Prasad, and E. Tuomanen. 1991. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J. Exp. Med. 173:1143-1149.
36. Shahin, R. D., M. J. Brennan, Z. M. Li, B. D. Meade, and C. R. Manclark. 1990. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis. J. Exp. Med. 171:63-73.
37. Simondon, F., M.-P. Preziosi, A. Yam, C. T. Kane, L. Chabirand, I. Iteman, G. Sanden, S. Mboup, A. Hoffen bach, K. Knudsen, N. Guiso, S. Wassilak, and M. Cadoz. 1997. A randomized double blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 15:1606-1612.
38. Torre, D., G. Ferrario, G. Bonetta, L. Perversi, R. Tambini, and F. Speranza. 1994. Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells. FEMS Immunol. Med. Microbiol. 9:183-188.
39. Trollofors, B., J. Taranger, T. Lagergard, L. Lind, V. Sundh, G. Zackrisson, C. U. Lowe, W. Blackwelder, and J. B. Robbins. 1995. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333:1045-1050.
40. Tuomanen, E. I., L. A. Zapiain, P. Galvan, and E. L. Hewlett. 1984. Characterization of antibody inhibiting adherence of Bordetella pertussis to human respiratory epithelial cells. J. Clin. Microbiol. 20:167-170.